Simon raises outlook on strong first-quarter earnings
The nation’s largest mall owner said funds from operations, a key measure of profitability, increased 15.4 percent in the first quarter while tenant rents grew.
Share prices
Articles
Stonegate Mortgage president gets keys to CEO’s office
The Indianapolis mortgage firm has promoted James Smith to the top spot vacated last year in an abrupt resignation by its founder.
Anthem slaps lawsuit on Express Scripts over drug pricing
The insurer’s CEO said in January that Anthem should be reaping an addition $3 billion per year in savings on drugs from Express Scripts, which manages its pharmacy benefits.
Simon reports lower quarterly profit, higher revenue
Despite reporting lower profit in the fourth quarter, the nation’s largest mall owner still posted strong results for the full year.
Anthem merger partner banned from Medicare sales for ‘widespread failures’
Cigna Corp., which has agreed to a $48 billion merger with Indianapolis-based Anthem Inc., has committed systemic violations that threatened patients’ health, U.S. regulators say.
Finish Line’s ‘self-inflicted’ blunders leave analysts skeptical
The Finish Line Inc.’s disastrous third quarter stemmed from management miscues, a well-worn story that has made some analysts skeptical that incoming CEO, Sam Sato, will usher in better times.
Large Noble Roman’s investor calls for sale of company
In a scathing letter to directors, Privet Fund LP said accountability is sorely lacking throughout the upper ranks of the company, which has a stock price languishing below $2 a share.
Aggressive bidder has Angie’s List over a barrel, analysts say
Internet behemoth IAC appears bent on hashing out an acquisition and likely would stage a hostile takeover if Angie’s List resists, market analysts say.
Simon raises quarterly dividend, full-year forecast
A strong third quarter prompted Simon to boost its earnings forecast and raise its quarterly dividend to $1.60 per share, a 23.1 percent year-over-year increase.
Angie’s List ekes out profit as new CEO rebuffs activist
Shares sank 15 percent on Wednesday morning despite an $82,000 profit in the third quarter. New CEO Scott Durchslag told analysts he wanted to increase shareholder value organically rather than pursue a sale or merger.
Lilly stock performs big despite analyst projections
Analysts have consistently given the Indianapolis-based company some of the lowest ratings among a group of 16 large drugmakers, but Lilly shares have been on a five-year rally.
Angie’s CEO vows to fix fundamentals, grow e-commerce
Analysts say the hiring of Scott Durchslag suggests Angie’s List is intent on a turnaround and not a sale. The new CEO shared his vision Tuesday.
Hedge fund ups Angie’s List holdings again, seeks board seats
Now with a 9-percent stake, New York-based TCS Capital Management says it’s after multiple board seats and plans to continue discussing options to maximize the firm’s value, including a sale.
Market plunge driven by fearful investors fizzles in U.S.
A wave of fear triggered by instability in China initially doused U.S. stocks on Monday morning, but then quickly receded by noon.
HHGregg’s latest loss still beats Wall Street expectations
The retailer reported another lackluster quarter with sales dips in every category except home products. But its shares shot up in trading because the results were better than expected.
Investors still cautious about antitrust scrutiny on Anthem-Cigna deal
The stock price for Cigna Corp. remained lethargic during trading Thursday, as another mega-merger of insurers complicated the Anthem deal and sparked antitrust concerns.
Alzheimer’s trials offer little certainty for investors, patients
Shares of Eli Lilly and Co. stagnated in Wednesday morning trading as investors and patients wished that the effects of solanezumab were more pronounced. Rival Biogen offered muddy results from its own Alzheimer’s drug.
Report: Simon attempts to sell holdings in rival Macerich
If true, the move could signal that Indianapolis-based Simon Property Group no longer is interested in acquiring the rival shopping-mall owner.
After long sales slide, HHGregg cuts ad spending, inventory
HHGregg Inc. has tried for four years to reverse sliding sales. That hasn’t worked, and now executives have turned their focus to slashing expenses in a quest to return to profitability next year.
Finish Line tightens laces, rebounds in fourth quarter
Reducing expenses and rejiggering inventory helped the Indianapolis-based retailer of athletic apparel finish a disappointing year with a strong kick.